Company news
M1 Kliniken Ag (XETR:M12) news
Every M1 Kliniken Ag press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
M1 Kliniken AG publishes Half-Year Report 2026: Beauty EBIT up 23.8% to EUR 18.6 million
September 9, 2026
M1 Kliniken AG increases core “Beauty” business EBIT by 37.6% to EUR 9.2 million and completes strategic refocusing
June 3, 2026
M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
May 26, 2026
M1 Kliniken AG publishes annual report for 2025: strong growth in EBIT (+29%) and earnings per share (+40%)
May 20, 2026
M1 Kliniken AG: Supervisory Board adopts annual financial statements 2025. Dividend proposal of EUR 1.20 per share
May 12, 2026
M1 Kliniken AG publishes preliminary figures for the 2025 financial year: strong growth in EBIT (+29%) and earnings per share (+40%)
April 22, 2026
M1 Kliniken AG: Completion of the Sale of 100% Subsidiary HAEMATO Pharm GmbH to PHOENIX group
February 2, 2026
Expansion of the Management Board of M1 Kliniken AG
December 11, 2025
M1 Kliniken AG Reports Strong EBIT Growth of 11% and Achieves Earnings per Share of EUR 0.86
November 18, 2025
M1 Kliniken AG: Successful First Half of 2025 with EBIT Growth of 24% and Earnings per Share of EUR 0.63
September 9, 2025
M1 Kliniken AG: Strong Q1 2025 with 29% EBIT Growth and Earnings per Share of EUR 0.31
June 5, 2025
M1 Kliniken AG: Strong Earnings Growth in 2024 – Strategic Focus on Global Market Leadership
May 21, 2025
M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings ...
April 29, 2025
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
November 19, 2024
Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
September 3, 2024
M1 Kliniken AG: Management Board confirms growth targets
June 21, 2024